Does the ‘gateway’ matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication
Identifieur interne : 000388 ( Ncbi/Curation ); précédent : 000387; suivant : 000389Does the ‘gateway’ matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication
Auteurs : L. Degenhardt [Australie] ; W. T. Chiu [États-Unis] ; K. Conway [États-Unis] ; L. Dierker [États-Unis] ; M. Glantz [États-Unis] ; A. Kalaydjian [États-Unis] ; K. Merikangas [États-Unis] ; N. Sampson [États-Unis] ; J. Swendsen [France] ; R. C. Kessler [États-Unis]Source :
- Psychological medicine [ 0033-2917 ] ; 2008.
Abstract
The ‘gateway’ pattern of drug initiation describes a normative sequence, beginning with alcohol and tobacco use, followed by cannabis, then other illicit drugs. Previous work has suggested that ‘violations’ of this sequence may be predictors of later problems but other determinants were not considered. We have examined the role of pre-existing mental disorders and sociodemographics in explaining the predictive effects of violations using data from the US National Comorbidity Survey Replication (NCS-R).
The NCS-R is a nationally representative face-to-face household survey of 9282 English-speaking respondents aged 18 years and older that used the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) to assess DSM-IV mental and substance disorders. Drug initiation was estimated using retrospective age-of-onset reports and ‘violations’ defined as inconsistent with the normative initiation order. Predictors of violations were examined using multivariable logistic regressions. Discrete-time survival analysis was used to see whether violations predicted progression to dependence.
Gateway violations were largely unrelated to later dependence risk, with the exception of small increases in risk of alcohol and other illicit drug dependence for those who initiated use of other illicit drugs before cannabis. Early-onset internalizing disorders were predictors of gateway violations, and both internalizing and externalizing disorders increased the risks of dependence among users of all drugs.
Drug use initiation follows a strong normative pattern, deviations from which are not strongly predictive of later problems. By contrast, adolescents who have already developed mental health problems are at risk for deviations from the normative sequence of drug initiation and for the development of dependence.
Url:
DOI: 10.1017/S0033291708003425
PubMed: 18466664
PubMed Central: 2653272
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001441
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :001301
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002A18
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000388
Links to Exploration step
PMC:2653272Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does the ‘gateway’ matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication</title>
<author><name sortKey="Degenhardt, L" sort="Degenhardt, L" uniqKey="Degenhardt L" first="L." last="Degenhardt">L. Degenhardt</name>
<affiliation wicri:level="1"><nlm:aff id="A1"> National Drug and Alcohol Research Centre, University of NSW, Sydney, NSW, Australia</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea> National Drug and Alcohol Research Centre, University of NSW, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chiu, W T" sort="Chiu, W T" uniqKey="Chiu W" first="W. T." last="Chiu">W. T. Chiu</name>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Health Care Policy, Harvard Medical School, Boston, MA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea> Department of Health Care Policy, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Conway, K" sort="Conway, K" uniqKey="Conway K" first="K." last="Conway">K. Conway</name>
<affiliation wicri:level="2"><nlm:aff id="A3"> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Dierker, L" sort="Dierker, L" uniqKey="Dierker L" first="L." last="Dierker">L. Dierker</name>
<affiliation wicri:level="2"><nlm:aff id="A4"> Department of Psychology, Wesleyan University, Middletown, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Psychology, Wesleyan University, Middletown, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Glantz, M" sort="Glantz, M" uniqKey="Glantz M" first="M." last="Glantz">M. Glantz</name>
<affiliation wicri:level="2"><nlm:aff id="A3"> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kalaydjian, A" sort="Kalaydjian, A" uniqKey="Kalaydjian A" first="A." last="Kalaydjian">A. Kalaydjian</name>
<affiliation wicri:level="2"><nlm:aff id="A5"> National Institute of Mental Health, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> National Institute of Mental Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Merikangas, K" sort="Merikangas, K" uniqKey="Merikangas K" first="K." last="Merikangas">K. Merikangas</name>
<affiliation wicri:level="2"><nlm:aff id="A5"> National Institute of Mental Health, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> National Institute of Mental Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sampson, N" sort="Sampson, N" uniqKey="Sampson N" first="N." last="Sampson">N. Sampson</name>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Health Care Policy, Harvard Medical School, Boston, MA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea> Department of Health Care Policy, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Swendsen, J" sort="Swendsen, J" uniqKey="Swendsen J" first="J." last="Swendsen">J. Swendsen</name>
<affiliation wicri:level="3"><nlm:aff id="A6"> Psychopathology Research Laboratory, University of Bordeaux, Bordeaux, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea> Psychopathology Research Laboratory, University of Bordeaux, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kessler, R C" sort="Kessler, R C" uniqKey="Kessler R" first="R. C." last="Kessler">R. C. Kessler</name>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Health Care Policy, Harvard Medical School, Boston, MA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea> Department of Health Care Policy, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">18466664</idno>
<idno type="pmc">2653272</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653272</idno>
<idno type="RBID">PMC:2653272</idno>
<idno type="doi">10.1017/S0033291708003425</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">001441</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001441</idno>
<idno type="wicri:Area/Pmc/Curation">001301</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001301</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002A18</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002A18</idno>
<idno type="wicri:Area/Ncbi/Merge">000388</idno>
<idno type="wicri:Area/Ncbi/Curation">000388</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Does the ‘gateway’ matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication</title>
<author><name sortKey="Degenhardt, L" sort="Degenhardt, L" uniqKey="Degenhardt L" first="L." last="Degenhardt">L. Degenhardt</name>
<affiliation wicri:level="1"><nlm:aff id="A1"> National Drug and Alcohol Research Centre, University of NSW, Sydney, NSW, Australia</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea> National Drug and Alcohol Research Centre, University of NSW, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chiu, W T" sort="Chiu, W T" uniqKey="Chiu W" first="W. T." last="Chiu">W. T. Chiu</name>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Health Care Policy, Harvard Medical School, Boston, MA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea> Department of Health Care Policy, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Conway, K" sort="Conway, K" uniqKey="Conway K" first="K." last="Conway">K. Conway</name>
<affiliation wicri:level="2"><nlm:aff id="A3"> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Dierker, L" sort="Dierker, L" uniqKey="Dierker L" first="L." last="Dierker">L. Dierker</name>
<affiliation wicri:level="2"><nlm:aff id="A4"> Department of Psychology, Wesleyan University, Middletown, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Psychology, Wesleyan University, Middletown, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Glantz, M" sort="Glantz, M" uniqKey="Glantz M" first="M." last="Glantz">M. Glantz</name>
<affiliation wicri:level="2"><nlm:aff id="A3"> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea> Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, US National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kalaydjian, A" sort="Kalaydjian, A" uniqKey="Kalaydjian A" first="A." last="Kalaydjian">A. Kalaydjian</name>
<affiliation wicri:level="2"><nlm:aff id="A5"> National Institute of Mental Health, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> National Institute of Mental Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Merikangas, K" sort="Merikangas, K" uniqKey="Merikangas K" first="K." last="Merikangas">K. Merikangas</name>
<affiliation wicri:level="2"><nlm:aff id="A5"> National Institute of Mental Health, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> National Institute of Mental Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sampson, N" sort="Sampson, N" uniqKey="Sampson N" first="N." last="Sampson">N. Sampson</name>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Health Care Policy, Harvard Medical School, Boston, MA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea> Department of Health Care Policy, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Swendsen, J" sort="Swendsen, J" uniqKey="Swendsen J" first="J." last="Swendsen">J. Swendsen</name>
<affiliation wicri:level="3"><nlm:aff id="A6"> Psychopathology Research Laboratory, University of Bordeaux, Bordeaux, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea> Psychopathology Research Laboratory, University of Bordeaux, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kessler, R C" sort="Kessler, R C" uniqKey="Kessler R" first="R. C." last="Kessler">R. C. Kessler</name>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Health Care Policy, Harvard Medical School, Boston, MA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea> Department of Health Care Policy, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Psychological medicine</title>
<idno type="ISSN">0033-2917</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">The ‘gateway’ pattern of drug initiation describes a normative sequence, beginning with alcohol and tobacco use, followed by cannabis, then other illicit drugs. Previous work has suggested that ‘violations’ of this sequence may be predictors of later problems but other determinants were not considered. We have examined the role of pre-existing mental disorders and sociodemographics in explaining the predictive effects of violations using data from the US National Comorbidity Survey Replication (NCS-R).</p>
</sec>
<sec sec-type="methods" id="S2"><title>Method</title>
<p id="P2">The NCS-R is a nationally representative face-to-face household survey of 9282 English-speaking respondents aged 18 years and older that used the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) to assess DSM-IV mental and substance disorders. Drug initiation was estimated using retrospective age-of-onset reports and ‘violations’ defined as inconsistent with the normative initiation order. Predictors of violations were examined using multivariable logistic regressions. Discrete-time survival analysis was used to see whether violations predicted progression to dependence.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Gateway violations were largely unrelated to later dependence risk, with the exception of small increases in risk of alcohol and other illicit drug dependence for those who initiated use of other illicit drugs before cannabis. Early-onset internalizing disorders were predictors of gateway violations, and both internalizing and externalizing disorders increased the risks of dependence among users of all drugs.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Drug use initiation follows a strong normative pattern, deviations from which are not strongly predictive of later problems. By contrast, adolescents who have already developed mental health problems are at risk for deviations from the normative sequence of drug initiation and for the development of dependence.</p>
</sec>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000388 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000388 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:2653272 |texte= Does the ‘gateway’ matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:18466664" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |